Abstract:

OBJECTIVE—The goal of this study was to estimate the prevalence of diabetes and complications of the number of people of all ages with diabetes those got attended in OPD of Diabetes of Hospital central Nampula.

RESEARCH DESIGN AND METHODS—Data on diabetes prevalence limited 24 patient randomly selected of OPD of central Hospital Nampula. Patients were taken information regarding Identification, history & physical examinations. There were used results of Investigations of hematological, biochemistry etc, Radiologic examination if needed, Monofilament test, Tunic fork, ophthalmoscope, blood pressure apparatus, Glucometer.

RESULTS— During evolution of patient of OPD of Diabetes in Central Hospital Nampula found, DM 1 was less than 15 years of age group and DM 2 start from age 31 and picks age 46 to 60 years. There was male sex had higher % of DM it also related to culture as male was more sedentary life style did manual work and women were used to do house work which taken physical work. There were profession which involved life style sedentary, high calories intake, rich in economy professors and student, Urbanization also was one factor which responsible for development of Diabetes. There were most common complication Diabetic Neuropathy and impotency but less common Diabetic Retinopathy and Nephropathy.

CONCLUSIONS—Which suggest improvement of facility of diagnosis various complication, education of patient availability of drugs, adherence of treatment, awareness of general population and professional regarding Diabetes mellitus in Nampula.

Keywords: DM1, DM2, BP, OPD, GDM, AMODIA

References:

[1.] Abbas, Z., J. Lutale, and S. Morback. 2000. “Outcome of Hospital Admissions for Diabetic Foot Lesions at Muhimbili Medical Centre, Dar es Salaam, Tanzania.” Diabetologia 43 (Suppl. 1): A246

[2.] Abdullah, A; Peeters, A; de Courten, M; Stoelwinder, J (September 2010). "The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies.". Diabetes research and clinical practice89 (3): 309–19. PMID 20493574, Retrieved from www.google.com

[3.] Alexander,R. D., Berkes, S. L., and Abuelo, J. G.: Contrast Media-Induced Oliguric Renal Failure. Arch. Intern. Med.138: 381-84, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[4.] Amos, A. F., D. J. McCarty, and P. Zimmet. 1997. “The Rising Global Burden of Diabetes and Its Complications: Estimates and Projections to the Year 2010.” Diabetic Medicine 14: S1–85.

[5.] Anja Schienkiewitz, Matthias B Schulze, Kurt Hoffmann, Anja Kroke, and Heiner Boeing 2006, Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC), American Society for Clinical Nutrition, Retrieved from http://ajcn.nutrition.org/content/84/2/427.long

[6.] Bar, R. S., and Roth, J.: Arch. Intern. Insulin Receptor Status in Disease States of Man. Med. 137: 474-81, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[7.] Beran, D. The Diabetes Foundation Report on implementing national diabetes programmes in sub-Saharan Africa.London : International Insulin Foundation, 2006.

[8.] Beran, D, Yudkin, J S and de Courten, M. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care. 2005, Vol. 28, 9, pp. 2136-40.

[9.] Beran, D, Yudkin, J S and de Courten, M. Assessing health systems for insulin-requiring diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'. 2006,Vol. 6, 1, p. 17.

[10.] Bethel, edited by Mark N. Feinglos, M. Angelyn (2008). Type 2 diabetes mellitus : an evidence-based approach to practical management. Totowa, NJ: Humana Press. p. 462. ISBN 978-1-58829-794-5

[11.] Boulton, A. 1990. Practical Diabetes Digest 1: 35–37. Castle,W. N., and A. C. B.Wicks. 1980.“Follow-Up of 93 Newly Diagnosed African Diabetics for 6 Years.” Diabetologia 18: 121–23

[12.] Campbell,L. V., Kraegen, E. W., and Lazarus, L. Defective Blood Glucose Counter-regulation in Diabetics is a Selective Form of Autonomic Neuropathy.: Br. Med. J. 2: 1527-29, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[13.] Castle,W. N., and A. C. B.Wicks. 1980.“Follow-Up of 93 Newly Diagnosed African Diabetics for 6 Years.” Diabetologia 18:121–23.

[14.] Cooper, R., C. Rotimi, J. Kaufman, E. Owoaje, H. Fraser, T. Forester, R.Wilks, L. K. Riste, and J. K.Cruikshank. 1997.“Prevalence of NIDDM among Populations of the African Diaspora.”Diabetes Care 20: 343–48.

[15.] Davis, J. W., Phillips, P. E., Yue, K. T. N., Lewis, H. D., Jr., and Hartman, C. R.: Platelet Aggregation. Adult-Onset Diabetes Mellitus and Coronary Artery Disease. J.A.M.A.239: 732-34, 1978. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[16.] Deeb, L, Tan, M and Alberti, K. Insulin availability among International Diabetes Federationmember associations. Diabetes Care. 1994, Vol. 17, 3, pp. 220-3.

[17.] Diallo, A. D., D. Nochy, E. Niamkey, and B. Yao Beda. 1997. “Etiologic Aspects of Nephrotic Syndrome in Black African Adults in a Hospital Setting in Abidjan.” Bulletin Société Pathologie Exotique 90: 342–45.

[18.] Ditzel, J. and Kjaergaard, J. J.: Haemoglobin Alc Concentrations After Initial Insulin Treatment for Newly Discovered Diabetes. Br. Med. J. 1: 741-42, 1978. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[19.] Edwards, R., N. Unwin, F. Mugusi, D. Whiting, S. Rashid, J. Kissima, T. J. Aspray, and K. G. Alberti. 2000.“Hypertension Prevalence and Care in an Urban and Rural Area of Tanzania.” Journal of Hypertension 18 (2): 145–52.

[20.] Fisch, A., E. Pichard, T. Prazuck, H. Leblanc, Y. Sidibe, and G. Brucker.1987. “Prevalence and Risk Factors of Diabetes Mellitus in the Rural Region of Mali West Africa: A Practical Approach.” Diabetologia 30:859–62.

[21.] Forland, M., Thomas, V., and Shelokov, A.: Urinary Tract Infections in Patients with Diabetes Mellitus. Studies on Antibody Coating of Bacteria. J.A.M.A. 238: 1924-26, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[22.] Gale EA1, Gillespie KM.(2001): Diabetes and gender. Diabetologia. 2001 Jan;44(1):3-15. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11206408

[23.] Ganda, O. P., and Soeldner, J. S.: Genetic, Acquired, and Related Factors in the Etiology of Diabetes Mellitus. Arch. Intern. Med. 137: 461-69, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[24.] Gassull, M. A., and Hockaday, T. D. R.: Lancet 2: Unabsorbable Carbohydrates and Diabetes: Decreased Post-Prandial Hyperglycaemia. 172 — 74,1976. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[25.] Gill, G. V. 1997. “Outcome of Diabetes in Africa.” In Diabetes in Africa, ed. G. V. Gill, J.-C. Mbanya, and K. G. M. M. Alberti, 65–71. Cambridge: FSG Communications

[26.] Gonen, B., Rochman, H., Rubenstein,A. H., Tanega, S. P., and Horwitz, D. L.: Hemoglobin Al: An Indicator of the Metabolic Control of Diabetic Patients. Lancet 2: 734-36, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

http://www.dhnet.org.br/dados/cursos/dh/br/pb/dhparaiba/5/mulher2

http://www.bloodpressureuk.org/BloodPressureandyou/Homemonitoring/Howtomeasure

http://www.dhnet.org.br/dados/cursos/dh/br/pb/dhparaiba/5/

[27.] World Health Organization. Welcome to the diabetes programme. [Online] 2006. [Cited: 7March 2007.] www.who.int/diabetes/en.

[28.] United Nations General Assembly. World Diabetes Day. New York : 2006.

[29.] International Diabetes Federation. About insulin. [Online] [Cited: 6 February 2007.] www.idf.org/home/index.cfm?unode=1DA26AAB-E840-4F76-B399-EDE131A4C2E7.

[30.] Bliss, M. The discovery of insulin. Chicago : University of Chicago Press, 1984.

[31.] International Diabetes Federation. International Diabetes Federation Diabetes Atlas 3rdEdition. Brussels : International Diabetes Federation, 2006.

[32.] International Diabetes Federation. Task Force Initiatives. International Diabetes Federation.[Online] 2009. [Cited: 11 July 2009.] www.idf.org/node/1220?unode=6C3366C1-8074-47F7-A4F7-7D8E67E10354.

[33.] Central Intelligence Agency. Mozambique Country Profile. World Factbook. [Online] 1 July2009. [Cited: 11 July 2009.] www.cia.gov/library/publications/the-world-factbook/geos/MZ.html.

[34.] Programa das Nações Unidas para o Desenvolvimento. Relatório Nacional de Desenvolvimento Humano 2005. Maputo : Programa das Nações Unidas para o Desenvolvimento,2006.

[35.] United Nations Development Programme. Human Development Report 2007/2008. NewYork : United Nations Development Programme, 2007.

[36.] World Bank. Project Appraisal Document. Washington : World Bank, 2009.

[37.] World Health Organization. Mozambique's Health System. Health and Development. [Online] 2009. [Cited: 5 March 2009.] www.who.int/countries/moz/areas/health_system/en/index1.html.

[38.] http://diabetes.niddk.nih.gov/dm/pubs/riskfortype2/

[39.] http://www.ahrq.gov/research/findings/factsheets/diabetes/diabdisp/index.html

[40.] Ministério da Saúde. Plano Estratégico Nacional de Prevenção e Controlo das Doenças NãoTransmissíveis para o período 2008-2014. Maputo : Ministério d Saúde, 2008.

[41.] https://jdrf.org/life-with-t1d/type-1-diabetes-information/diabetes-complications/

[42.] http://www.diabetes.org/diabetes-basics/genetics-of-diabetes.html

[43.] Irvine, W. J.: Classification of Idiopathic Diabetes. Lancet 1: 638-42, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[44.] Irvine, W. J-, Holton, D. E., Clarke, B. F., Toft,A. D., Prescott, R. J., and Duncan, Familial Studies of Type-I and Type-II Idiopathic Diabetes Mellitus. L. J. P.: Lancet 2: 325-28, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[45.] Irvine W. J., Gray, R. S., McCallum,C. J., and Duncan, L. J. P.: Clinical and Pathogenic Significance of Pancreatic-Islet- Cell Antibodies in Diabetics Treated with Oral HypoglycaemicAgents., Lancet 1: 1025-27, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[46.] Jenkins, D. J. A., Leeds, A. R., Wolever, T. M. S., Goff, D. V., Alberti, K. G. M. M., Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[47.] Jenkins, D. J. A., Leeds, A. R., Gassull, M. A., Cochet, B., and Alberti, K. G. M. M.: Decrease in Postprandial Insulin and Glucose Concentrations by Guar and Pectin. Ann.Intern. Med. 86: 20-23, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[48.] Kalk, W. J., J. Joannou, S. Ntsepo, I. Mahomed, P. Mahanlal, and P. J. Becker. 1997. “Ethnic Differences in the Clinical and Laboratory Associations with Retinopathy in Adult Onset Diabetes: Studies in Patients of African, European and Indian Origins.” Journal of Internal Medicine 241: 31–37.

[49.] Koivisto, V. A., and Felig, P.: Effects of Leg Exercise on Insulin Absorption in Diabetic

[50.] Patients. N. Engl. J. Med.298: 79-83, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[51.] Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Cotran, Ramzi S. ; Robbins, Stanley L. (2005). Robbins and Cotran Pathologic Basis of Disease (7th ed.). Philadelphia, Pa.: Saunders. pp. 1194–1195. ISBN 0-7216-0187-1

[52.] Kurtz, A. B., Daggett, P. R., Mustaffa, B. E., and Nabarro, Effect of Insulin Antibodies on Free and Total Plasma' Insulin. J. D. N.: Lancet 2: 56-58, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[53.] Lendrum, R.,Walker, G., Cudworth, A. G., Theophanides, C, Pyke, D. A., Bloom, A., and Gamble, D. R.: Islet-Cell Antibodies in Diabetes Mellitus, Lancet 2: 1273-76, 1976. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[54.] Levitt, N. S., J. M. Katzenellenbogen, D. Bradshaw, M. N. Hoffman, and F. Bonnici. 1993. “The Prevalence and Identification of Risk Factors for NIDDM in Urban Africans in Cape Town, South Africa.” Diabetes Care 16: 601–7.

[55.] Mako, M. E., Starr, J. I., and Rubenstein, A. H.: Circulating Proinsulin in Patients with Maturity Onset Diabetes. Am. J. Med. 63: 865-69, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[56.] Malik, VS; Popkin, BM, Bray, GA, Després, JP, Hu, FB (2010-03-23). "Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk.". Circulation 121 (11): 1356

doi:10.1161/CIRCULATIONAHA.109.876185.PMC 2862465. PMID 20308626

[57.] Malik, VS; Popkin, BM, Bray, GA, Després, JP, Willett, WC, Hu, FB (November 2010). "Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis.". Diabetes Care 33 (11): 2477–83. doi:10.2337/dc10- 1079.PMC 2963518. PMID 20693348.

[58.] Mbanya, J. C., and E. Sobngwi. 2003. “Diabetes Microvascular and Macrovascular Disease in Africa.” Journal of Cardiovascular Risk 10: 97–102.

[59.] Mbanya, J. C., L. N. Pani,D. N. Mbanya, E. Sobngwi, and J. Ngogang. 2000. “Reduced Insulin Secretion in Offspring of African Type 2 Diabetic Parents.” Diabetes Care 23: 1761–65

[60.] Mbanya, J. C., J. Ngogang, J. N. Salah, E. Minkoulou, and B. Balkau.1997. “Prevalence of NIDDM and Impaired Glucose Tolerance in a Rural and an Urban Population in Cameroon.” Diabetologia 40:824–29.

[61.] McLarty, D. G., L. Kinabo, and A. B. M. Swai. 1990. “Diabetes in Tropical Africa: A Prospective Study, 1981–7. II. Course and Prognosis.” British Medical Journal 300: 1107–10.

[62.] McLarty, D, Swai, A and Alberti, K. Insulin availability in Africa: an insoluble problem? Int Diabetes Digest. 1994, Vol. 5, pp. 15-17.

[63.] McLarty, D. G., A. B. M. Swai, H. M. Kitange, G. Masuki, B. L. Mtinangi, P. M. Kilima, W. J. MaKene, L. M. Chuwa, and K. G. Alberti. 1989. “Prevalence of Diabetes and Impaired Glucose Tolerance in Rural Tanzania.” Lancet (8643): 871–75

[64.] Mennen, L. I., J. C. Mbanya, J. Cade, B. Balkau, S. Sharma, S. Chungong, and J. Kennedy 2000. “The Habitual Diet in Rural and Urban Cameroon.” European Journal of Clinical Nutrition 24: 882–87.

[65.] Mgllitiis. Reckless, J. P. D., Betteridge, D. J., Wu, P., Payne, B., and Galton, D. J.: High'Density and Low-Density Lipoproteins and Prevalence of Vascular Disease in Diabetes Br.Med. J. 1: 883-86, 1978. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[66.] Miranda, P. M., and Horwitz, D. L.: High-Fiber Diets in the Treatment of Diabetes Mellitus.Ann. Intern. Med. 88: 482-86, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[67.] Omar, M. A., M. A. Seedat, R. B. Dyer, A. A. Motala, L. T. Knight, and P. J. Becker. 1994. “South African Indians Show a High Prevalence of NIDDM and Bimodality in Plasma Glucose Distribution Patterns.” Diabetes Care 17: 70–74.

[68.] Omar,M. A. K., M. A. Seedat, A. A.Motala, R. B. Dyer, and P. Becker. 1993. “The Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in a Group of South African Blacks.” South African Medical Journal 83: 641–43.

[69.] Perez, G. O., Lespier, L., Knowles, R., Oster, J. R., and Vaamonde, C. A.: Potassium Homeostasis in Chronic Diabetes Mellitus. Arch. Intern. Med. 137: 1018-22, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[70.] Peterson, C. M., Jones, R. L., Koenig, R. J., Melvin, E. T., and Lehrman, M. L.: Reversible Hematologic Sequelae of Diabetes Mellitus. Ann. Intern. Med. 86: 425-29, 1977 Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf.

[71.] Rahlenbeck, S. I., and A. Gebre-Yohannes. 1997. “Prevalence and Epidemiology of Micro- and Macroalbuminuria in Ethiopian Diabetic Patients.” Journal of Diabetes Complications 11: 343–49.

[72.] Ramaiya,K. L., A. B. M. Swai,D. G.McLarty, and K. G. M.M.Alberti. 1991“Impaired Glucose Tolerance and Diabetes Mellitus in Hindu Indian Immigrants in Dar es Salaam.”Diabetic Medicine 8: 738–44

[73.] Ripsin CM, Kang H, Urban RJ (January 2009). "Management of blood glucose in type 2 diabetes mellitus". Am Fam Physician 79 (1): 29–36. PMID 19145963.

[74.] Ripsin CM, Kang H, Urban RJ (January 2009). "Management of blood glucose in type 2 diabetes mellitus". Am Fam Physician 79 (1): 29–36. PMID 19145963.

[75.] Risérus U, Willett WC, Hu FB (January 2009). "Dietary fats and prevention of type 2 diabetes". Progress in Lipid Research 48 (1): 44–51. doi:10.1016/j.plipres.2008.10.002. PMC 2654180. PMID 19032965

[76.] Risérus U, Willett WC, Hu FB (January 2009). "Dietary fats and prevention of type 2 diabetes". Progress in Lipid Research48 (1): 44–doi:10.1016/j.plipres.2008.10.002. PMC 2654180. PMID 19032965.

[77.] Rolfe, M. 1997. “Chronic Complications of Diabetes in Africa.” In Diabetes in Africa, ed. G. V. Gill, J.-C. Mbanya, and K. G. M. M. Alberti, 43–50. Cambridge: FSG Communications. ———. 1988. “The Neurology of Diabetes Mellitus in Central Africa.” Diabetic Medicine 5: 399–401.

[78.] Rubenstein, A. H., Kuzuya, H., and Horwitz, D. L.: Clinical Significance of Circulating C-Peptide in DiabetesMellitus and Hypoglycemic Disorders. Arch. Intern. Med. 137:625-32, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[79.] Rwiza, H. T., A. B.M. Swai, and D. G.McLarty. 1986. “Failure to Diagnose Diabetic Ketoacidosis in Tanzania.” Diabetic Medicine 3: 181–83.

[80.] Sartor, G.,Schersten, B., and Melander, A.: Effects of Glipizide and Food Intake on the Blood Levels ofGlucose and Insulin in Diabetic Patients. Acta Med. Scand. 203: 211-14, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[81.] Savage, A. The insulin dilemma: a survey of insulin treatment in the tropics. Int Diabetes Digest.1994, Vol. 5, pp. 19-20.

[82.] Seneviratne,B. I. B.: Diabetic Cardiomyopathy: the Preclinical Phase. Br. Med. J. 1: 1444-46, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[83.] Smyth, S; Heron, A (January 2006). "Diabetes and obesity: the twin epidemics". Nature Medicine 12 (1): 75– 80.doi:10.1038/nm0106-75. PMID 16397575

[84.] Sobngwi, E., J. C. Mbanya, N. C. Unwin, A. P. Kengne, L. Fezeu, E. M. Minkoulou, T. J. Aspray, and K. G. Alberti. 2002. “Physical Activity and Its Relationship with Obesity, Hypertension and Diabetes in Urban and Rural Cameroon.”

[85.] International Journal of Obesity and Related Metabolic Disorders 26: 1009–16.

[86.] Sobngwi, E., E. Mauvais-Jarvis, P. Vexiau, J. C. Mbanya, and J. F. Gautier.2001. “Diabetes in Africans. Part 1: Epidemiology and Clinical Specificities.” Diabetes and Metabolism 27: 628–34.

[87.] Sonksen, P. H., Judd, S. L., and Lowy,C: Home Monitoring of Blood-Glucose. Method for Improving Diabetic Control. Lancet 1: 729-32, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[88.] Swai, A. B. M., J. Lutale, and D. G. McLarty. 1990. “Diabetes in Tropical Africa: A Prospective Study 1981–7:Characteristics of Newly Presenting Patients in Dar es Salaam, Tanzania 1981–7.” British Medical Journal 300: 1103–7.

[89.] Taitelman, U., Reece, E. A., and Bessman, A. N.: J.A.M.A. 237: Insulin in the Management of the Diabetic Surgical Patient. Continuous Intravenous Infusion vs Subcutaneous Administration. 658-60, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[90.] Tamborlane, W. V., Sherwin, R. S., Hendler, R., and Felig, P.: Metabolic Effects of Somatostatin in Maturity-onset Diabetes. N. Engl. J. Med. 297: 181-83, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[91.] Thayssen, P., Roed-Petersen,K., Nielsen, F. U., Svendsen, V., and Kemp, E.: The Treatment of End-Stage Renal Failure in Insulindependent Diabetic Patients. Acta Med.

[92.] Scand. 201: 469-80, 1977. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[93.] Turner, R. C, and Holman, R. R.:Lancet 1: Insulin Rather Than Glucose Homoeostasis in the Pathophysiology of Diabetes. 1272-74, 1976. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[94.] Unger, R. H., and Orci, L.: Role of Glucagon in Diabetes.Arch. Intern. Med. 137: 482-91, 1977.

[95.] Vijan, S (2010-03-02). "Type 2 diabetes".Annals of internal medicine 152 (5): ITC31–15; quiz ITC316.doi:10.1059/0003-4819-152-5-201003020-01003. PMID 20194231

[96.] Walford, S., Allison, S. P., Gale, E. A. M., and Tattersall, R. B.: Self-Monitoring of Blood-Glucose. Improvement of Diabetic Control. Lancet: 1: 732-35, 1978. Retrieved from -http://care.diabetesjournals.org/content/1/6/367.full.pdf

[97.] Walker, R. W., D. G. McLarty, H. M. Kitange, D. Whiting, G. Masuki, D. M. Mtasiwa, H. Machibya, N. Unwin, and K. G. Alberti. 2000. “Stroke Mortality in Urban and Rural Tanzania.” Lancet 355: 1684–87.

[98.] Walsh, C. H., and Malins, J. M.: Br. Med. J. 2: Menstruation and Control of Diabetes. 177-79, 1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[99.] Williams textbook of endocrinology. (12th ed.). Philadelphia: Elsevier/Saunders.pp. 1371–1435. ISBN 978-1- 4377-0324-5

[100.] Williams textbook of endocrinology. (12th ed. ed.). Philadelphia: Elsevier/Saunders. pp. 1371–1435. ISBN 978-1-4377- 0324-5.Peter G. Kopelman, Ian D. Caterson, Michael J. Stock, William H. Dietz (2005). Clinical obesity in adults and children: In Adults and Children. Blackwell Publishing. p. 9. ISBN 1-4051-1672-2.

[101.] Yan-yan Li, Lian-sheng Wang, [...], and Ai-ling Chen CDKAL1 gene rs7756992 A/G polymorphism and type 2 diabetes mellitus: a meta-analysis of 62,567 subjects

[102.] Yudkin, J S, et al. Twinning for better diabetes care: a model for improving healthcare for noncommunicablediseases in resource-poor countries. PMJ. 2009, Vol. 85, 999, pp. 1-2.

[103.] Ziegler AG, Hummel M, Schenker M, Bonifacio E(1999): Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes48 :460–468,1999.

Retrieved from http://diabetes.diabetesjournals.org/content/54/suppl_2/S25.full

[104.] Zincke, H., Woods, J. E., Palumbo, P. J.,Leary, F. J., and Johnson, W. J.: Renal Transplantation in Patients with Insulin- Dependent Diabetes Mellitus. J.A.M.A. 237: 1101-3,1977. Retrieved from http://care.diabetesjournals.org/content/1/6/367.full.pdf

[105.] Zouvanis, M., A. C. Pieterse, H. C. Seftel, and B. I. Joffe. 1997. “Clinical Characteristics and Outcome.